The Stephen Hacala Poppy Seed Safety Act would require the Department of Health and Human Services (HHS) to establish contamination thresholds for morphine, codeine, and related opiates in poppy seeds. It directs HHS to issue a proposed rule within 12 months and to finalize that rule within 24 months.
Seeds that exceed these thresholds would be deemed adulterated under the Federal Food, Drug, and Cosmetic Act and barred from interstate commerce. The act preserves regulatory oversight under the Controlled Substances Act, clarifying that contaminated poppy seeds remain within federal control.
The findings that motivate the bill cite documented morphine exposure risks and warnings from multiple sectors, underscoring the public health rationale for a formal threshold and enforceable standards.
At a Glance
What It Does
The Secretary of Health and Human Services must issue a proposed rule within 1 year setting contamination levels for morphine, codeine, and designated alkaloids in poppy seeds, and finalize the rule within 2 years. Once finalized, seeds above the thresholds are adulterated under the FD&C Act and cannot be sold in interstate commerce.
Who It Affects
Food manufacturers, bakers, seed distributors, and importers that use poppy seeds in products sold nationwide; federal regulators at HHS and FDA who implement and enforce the rule; seed producers and suppliers facing new testing and sourcing requirements.
Why It Matters
It closes a regulatory gap by establishing objective, enforceable thresholds for contamination, reducing consumer exposure to opiate residues and providing a clear pathway for enforcement under federal food-safety law.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill targets the safety risks posed by poppy seeds contaminated with opiates. It anchors the framework in the federal food-safety regime by directing HHS to set specific levels of morphine, codeine, and related compounds in poppy seeds.
Those thresholds will determine when seeds are treated as adulterated and unlawful to distribute across state lines. The process is time-bound: a proposed rule must be issued within a year and finalized within two years after enactment.
The language makes sure adulterated seeds remain within the scope of federal regulation under the Federal Food, Drug, and Cosmetic Act, while also clarifying that existing oversight under the Controlled Substances Act remains applicable. The findings section highlights prior incidents and warnings to justify the need for measurable standards rather than vague safety claims.
Implementing these standards would provide producers and regulators with concrete criteria, improving traceability, testing, and compliance across the supply chain.
The Five Things You Need to Know
The bill requires HHS to set contamination thresholds for morphine, codeine, and related alkaloids in poppy seeds.
A proposed rule must be issued within 1 year, and a final rule within 2 years of enactment.
Seeds exceeding the thresholds are adulterated under the FD&C Act and barred from interstate commerce.
Contaminated seeds are still subject to regulation under the Controlled Substances Act.
The bill is named to reflect public-health concerns linked to poppy-seed consumption and morphine exposure.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short Title
This act may be cited as the Stephen Hacala Poppy Seed Safety Act. The title signals the federal scope of the policy and serves as the anchor for the regulatory arc proposed in the following sections.
Findings and Purpose
The bill catalogs a series of findings about health risks from contaminated poppy seeds, including documented morphine exposure and related concerns at hospitals and in the military. The purpose is to establish objective contamination levels that would render seeds adulterated and thus unlawful in interstate commerce, providing a clear standard for enforcement and compliance across the supply chain.
Unsafe Poppy Seeds as Adulterants
Section 3 directs HHS to issue a proposed rule within 1 year establishing contamination thresholds for morphine, codeine, and other designated compounds, and to finalize the rule within 2 years. Once final, seeds above these thresholds would be deemed adulterated under the FD&C Act, enabling the usual interstate commerce restrictions and enforcement mechanisms.
CSA Regulation Preserved
The act makes explicit that nothing herein exempts seeds contaminated by morphine, codeine, or other designated alkaloids from regulation under the Controlled Substances Act. This preserves the existing framework for controlling opiate-containing materials, even as seed-level adulteration standards are implemented under food-safety law.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Large-scale food manufacturers and bakers that use poppy seeds and could achieve clearer compliance standards, reducing liability from adulterated lots.
- Seed importers and suppliers who can converge on uniform testing and certification requirements to meet federal thresholds.
- Federal regulators at HHS and FDA who gain a clear, enforceable standard to apply across products and supply chains.
- Public health advocates and consumer-safety groups seeking concrete measures to limit opiate exposure from food.
- Hospitals and pharmacies that face risks from contaminated ingredients but benefit from stronger screening and traceability.
Who Bears the Cost
- Seed and ingredient suppliers may incur testing, certification, and traceability costs to demonstrate compliance.
- Small and mid-sized food producers may bear higher costs from sourcing compliant poppy seeds or performing required testing.
- Regulators and laboratories face ongoing resource needs to establish, administer, and enforce the new thresholds.
- Distributors and retailers may need to adjust inventories and supplier vetting to avoid noncompliant lots.
- Enforcement actions could impose procedural costs on parties involved in challenged shipments.
Key Issues
The Core Tension
The central tension is between protecting public health through concrete safety thresholds and the practical realities of testing, enforcing, and adapting supply chains to new federal criteria. A lower threshold improves safety but raises costs and compliance complexity; a higher threshold reduces immediate burden but risks allowing adulterated seeds to slip into commerce. The bill attempts to balance these competing interests through a defined, staged rulemaking process, but the outcome hinges on data, testing capabilities, and administrative capacity.
The act introduces a health-driven safeguard by setting measurable contamination thresholds, but the move shifts significant regulatory burden onto industry and federal agencies. Implementing the thresholds will require reliable, reproducible testing methods and clear enforcement protocols to avoid supply-chain disruption while ensuring public health protection.
The timelines—proposed rule within 1 year and final rule within 2 years—provide a clock for rulemaking, but the availability of testing infrastructure and industry readiness will shape how smoothly compliance unfolds. The intersection with the CSA adds another layer of regulatory coordination, ensuring that adulterated seeds remain subject to controlled-substance controls even as they are removed from interstate food markets.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.